-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Mineralys Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2022 to 2024.
- Mineralys Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending December 31, 2024 was -1 USD/shares, a 66.7% decline year-over-year.
- Mineralys Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending December 31, 2024 was -3.66 USD/shares, a 83.9% decline year-over-year.
- Mineralys Therapeutics, Inc. annual Earnings Per Share, Basic for 2024 was -3.66 USD/shares, a 83.9% decline from 2023.
- Mineralys Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -1.99 USD/shares, a 65.5% increase from 2022.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)